Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 23;12(2):179.
doi: 10.3390/pathogens12020179.

Detection of Equine Papillomaviruses and Gamma-Herpesviruses in Equine Squamous Cell Carcinoma

Lea Miglinci  1 , Paul Reicher  1 , Barbara Nell  2 , Michelle Koch  1 , Christoph Jindra  1   3 , Sabine Brandt  1
Affiliations

Detection of Equine Papillomaviruses and Gamma-Herpesviruses in Equine Squamous Cell Carcinoma

Lea Miglinci et al. Pathogens. .

Abstract

Squamous cell carcinoma (SCC) seriously compromises the health and welfare of affected horses. Although robust evidence points to equine papillomavirus type 2 (EcPV2) causing genital lesions, the etiopathogenesis of equine SCC is still poorly understood. We screened a series of SCCs from the head-and-neck (HN), (peri-)ocular and genital region, and site-matched controls for the presence of EcPV2-5 and herpesvirus DNA using type-specific EcPV PCR, and consensus nested herpesvirus PCR followed by sequencing. EcPV2 DNA was detected in 45.5% of HN lesions, 8.3% of (peri-)ocular SCCs, and 100% of genital tumors, whilst control samples from tumor-free horses except one tested EcPV-negative. Two HNSCCs harbored EcPV5, and an ocular lesion EcPV4 DNA. Herpesvirus DNA was detected in 63.6%, 66.6%, 47.2%, and 14.2% of horses with HN, ocular, penile, and vulvar SCCs, respectively, and mainly identified as equine herpesvirus 2 (EHV2), 5 (EHV5) or asinine herpesvirus 5 (AsHV5) DNA. In the tumor-free control group, 9.6% of oral secretions, 46.6% of ocular swabs, 47% of penile samples, and 14.2% of vaginal swabs scored positive for these herpesvirus types. This work further highlights the role of EcPV2 as an oncovirus and is the first to provide information on the prevalence of (gamma-)herpesviruses in equine SCCs.

Keywords: EcPV2; SCC; equine papillomavirus; herpesviruses; horse; squamous cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. IARC . Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 64 WHO/IARC; Lyon, France: 1995. - PubMed
    1. Schiller J.T., Lowy D.R. Virus infection and human cancer: An overview. Recent Results Cancer Res. 2014;193:1–10. doi: 10.1007/978-3-642-38965-8_1. - DOI - PubMed
    1. Campo M.S. Introduction. In: Campo M.S., editor. Papillomavirus Research: From Natural History to Vaccines and Beyond. 1st ed. Caister Academic Press; Norfolk, UK: 2006. pp. 1–2.
    1. Whitley R. Herpesviruses. In: Baron S., editor. Medical Microbiology. 4th ed. University of Texas Medical Branch; Galveston, TX, USA: 1996. - PubMed
    1. Ackermann M. Pathogenesis of gammaherpesvirus infections. Vet. Microbiol. 2006;113:211–222. doi: 10.1016/j.vetmic.2005.11.008. - DOI - PubMed